Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.

Saved in:
Bibliographic Details
Title: Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Authors: Jayachandran Preetha C; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Meredig H; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Brugnara G; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Mahmutoglu MA; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Foltyn M; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Isensee F; Medical Image Computing, German Cancer Research Center, Heidelberg, Germany., Kessler T; Neurology Clinic, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany., Pflüger I; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Schell M; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Neuberger U; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Petersen J; Medical Image Computing, German Cancer Research Center, Heidelberg, Germany., Wick A; Neurology Clinic, Heidelberg University Hospital, Heidelberg, Germany., Heiland S; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Platten M; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany; Department of Neurology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Idbaih A; Sorbonne Université, Inserm, Institut du Cerveau, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Brandes AA; Department of Medical Oncology, Azienda USL of Bologna, Bologna, Italy., Winkler F; Neurology Clinic, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany., van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Nabors B; Department of Neurology and O'Neal Comprehensive Cancer Center, Division of Neuro-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Stupp R; Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Department of Neurological Surgery and Department of Neurology, Northwestern Medicine and Northwestern University, Chicago, IL, USA., Maier-Hein KH; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Medical Image Computing, German Cancer Research Center, Heidelberg, Germany., Gorlia T; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Wick W; Neurology Clinic, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany., Bendszus M; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., Vollmuth P; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: philipp.vollmuth@med.uni-heidelberg.de.
Source: The Lancet. Digital health [Lancet Digit Health] 2021 Dec; Vol. 3 (12), pp. e784-e794. Date of Electronic Publication: 2021 Oct 20.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-7500 (Electronic) Linking ISSN: 25897500 NLM ISO Abbreviation: Lancet Digit Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-7500
DOI:10.1016/S2589-7500(21)00205-3